Abstract
BackgroundTocilizumab (TCZ) and anti-tumor necrosis factor (TNF) biologic agents are key therapies in the management of rheumatoid arthritis (RA). They are considered to be equally effective and very few head-to-head...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have